Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microtubules are essential cytoskeletal components formed by the polymerization of alpha- and beta-tubulin heterodimers, playing critical roles in cell division, intracellular transport, and structural maintenance [7, 11]. The taxane binding site is a distinct hydrophobic pocket located on the luminal surface of the beta-tubulin subunit, specifically near the M-loop which is involved in lateral protofilament contacts [6, 12, 18]. Drugs such as paclitaxel and docetaxel bind to this site to promote tubulin assembly and stabilize the microtubule lattice against depolymerization [8, 10]. This stabilization suppresses the dynamic instability of microtubules, effectively freezing the mitotic spindle and causing cell cycle arrest at the metaphase-anaphase transition [7, 14]. The resulting mitotic catastrophe triggers programmed cell death (apoptosis), making this site a cornerstone target in the treatment of various malignancies, including breast, lung, and ovarian cancers [9, 15]. However, clinical utility is often challenged by the emergence of resistance mechanisms, such as the overexpression of the beta-III tubulin isoform (TUBB3) or drug efflux transporters like P-glycoprotein [1, 4, 9].
Binds to the taxane site on the beta-tubulin subunit of the microtubule, promoting tubulin polymerization and stabilizing existing microtubules against depolymerization, which suppresses dynamic instability and leads to mitotic arrest and apoptosis.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta-tubulin taxane binding site.